Aaron Berutti serves as Executive at TREACE MEDICAL CONCEPTS, INC., where they oversee executive responsibilities. Since joining the company, Aaron Berutti has executed 9 insider transactions totaling $57.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 9, 2025 involved selling 4,907 shares valued at $0.
Aaron Berutti currently holds 205,092 shares of TREACE MEDICAL CONCEPTS, INC. (TMCI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aaron Berutti has been a net buyer of TMCI stock. They have purchased $39.9K and sold $17.9K worth of shares.
Aaron Berutti's most recent insider trade was on Aug 9, 2025, when they sold 4,907 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 10, 2024 | TMCI | $0 | Payment | 1,815 | $N/A | Discretionary |
| Mar 8, 2024 | TMCI | $0 | Payment | 711 | $N/A | Discretionary |
| Jan 10, 2024 | TMCI | $0 | Award | 65,025 | $N/A | Discretionary |
| Mar 10, 2023 | TMCI | $0 | Award | 29,800 | $N/A | Discretionary |
| Mar 9, 2023 | TMCI | $17.9K | Sale | 733 | $24.41 | Discretionary |
| Nov 21, 2022 | TMCI | $39.9K | Purchase | 1,825 | $21.86 | Discretionary |
| Mar 8, 2022 | TMCI | $0 | Award | 11,950 | $N/A | Discretionary |